Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to -$61.4 million.

  • Adma Biologics' Enterprise Value rose 2920.41% to -$61.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.4 million, marking a year-over-year increase of 2920.41%. This contributed to the annual value of -$103.1 million for FY2024, which is 10086.27% down from last year.
  • Latest data reveals that Adma Biologics reported Enterprise Value of -$61.4 million as of Q3 2025, which was up 2920.41% from -$90.3 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Enterprise Value ranged from a high of -$34.4 million in Q3 2021 and a low of -$103.1 million during Q4 2024
  • Over the past 5 years, Adma Biologics' median Enterprise Value value was -$62.5 million (recorded in 2023), while the average stood at -$65.1 million.
  • Per our database at Business Quant, Adma Biologics' Enterprise Value skyrocketed by 4233.68% in 2021 and then tumbled by 11257.08% in 2023.
  • Over the past 5 years, Adma Biologics' Enterprise Value (Quarter) stood at -$51.1 million in 2021, then tumbled by 69.36% to -$86.5 million in 2022, then surged by 40.65% to -$51.4 million in 2023, then plummeted by 100.86% to -$103.1 million in 2024, then skyrocketed by 40.49% to -$61.4 million in 2025.
  • Its Enterprise Value stands at -$61.4 million for Q3 2025, versus -$90.3 million for Q2 2025 and -$71.6 million for Q1 2025.